| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| X4011 |
State-specific procedure code |
9,612 |
8,891 |
$2.04M |
| D7999 |
|
530 |
529 |
$2.01M |
| Y7506 |
|
601 |
591 |
$1.90M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,013 |
13,772 |
$1.29M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,816 |
6,470 |
$1.10M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,168 |
7,890 |
$958K |
| 80053 |
Comprehensive metabolic panel |
9,306 |
8,586 |
$722K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,344 |
1,262 |
$269K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,731 |
2,144 |
$226K |
| 81001 |
|
2,678 |
2,567 |
$190K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,929 |
1,856 |
$175K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,223 |
4,002 |
$163K |
| X4003 |
|
2,668 |
2,102 |
$119K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,617 |
1,548 |
$86K |
| 84703 |
|
273 |
264 |
$86K |
| 71046 |
Radiologic examination, chest; 2 views |
342 |
312 |
$71K |
| 87430 |
|
317 |
298 |
$64K |
| 71045 |
Radiologic examination, chest; single view |
1,196 |
1,129 |
$58K |
| 87081 |
|
257 |
240 |
$57K |
| 81003 |
|
239 |
234 |
$54K |
| 87420 |
|
333 |
293 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,287 |
2,197 |
$47K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
290 |
279 |
$44K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
526 |
516 |
$41K |
| 83690 |
|
683 |
668 |
$36K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
13 |
13 |
$34K |
| Y7507 |
|
69 |
67 |
$30K |
| 82150 |
|
91 |
89 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
823 |
782 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
544 |
510 |
$16K |
| 85610 |
|
329 |
306 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
74 |
73 |
$10K |
| 83880 |
|
67 |
63 |
$7K |
| G0378 |
Hospital observation service, per hour |
14 |
13 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
27 |
26 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
104 |
102 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
885 |
791 |
$5K |
| 59025 |
Fetal non-stress test |
45 |
39 |
$4K |
| 83735 |
|
237 |
227 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
218 |
163 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$3K |
| 85730 |
|
288 |
267 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
29 |
26 |
$3K |
| 36591 |
|
69 |
41 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
353 |
344 |
$2K |
| 73630 |
|
108 |
89 |
$2K |
| 84484 |
|
185 |
178 |
$2K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
25 |
25 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$2K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
28 |
14 |
$2K |
| 87070 |
|
227 |
220 |
$2K |
| 88312 |
|
43 |
42 |
$1K |
| 85651 |
|
96 |
95 |
$727.33 |
| 73564 |
|
12 |
12 |
$713.16 |
| 84443 |
Thyroid stimulating hormone (TSH) |
84 |
80 |
$702.02 |
| 80061 |
Lipid panel |
45 |
42 |
$550.60 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
43 |
42 |
$438.26 |
| 81025 |
|
78 |
73 |
$323.29 |
| 0002A |
|
18 |
18 |
$312.80 |
| 0001A |
|
24 |
24 |
$275.08 |
| 83605 |
|
40 |
38 |
$258.00 |
| 0012A |
|
15 |
15 |
$244.26 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
17 |
16 |
$238.09 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
13 |
$214.90 |
| 86140 |
|
24 |
24 |
$188.11 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$173.41 |
| 11721 |
|
42 |
39 |
$137.79 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$75.00 |
| 85652 |
|
12 |
12 |
$16.34 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
28 |
$0.07 |
| 36415 |
Collection of venous blood by venipuncture |
964 |
757 |
$0.00 |
| J3490 |
Unclassified drugs |
203 |
161 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
20 |
19 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
21 |
21 |
$0.00 |
| 90688 |
|
12 |
12 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,055 |
1,024 |
$0.00 |